Downgrade Alert for Galectin Therapeutic (GALT)

Galectin Therapeutic (NASDAQ:GALT) was downgraded from Outperform to Market Perform at FBR Capital today. The stock closed yesterday at $1.15 on volume of 816,000 shares, above average daily...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.